Revue médicale suisse
-
Mindfulness based therapies are nowadays widely spread. During the last decades, several approches and specific programs have been scientifically challenged and developped. ⋯ It also has a favorable impact when dealing with craving. Currently, the scientific research has come to promissing conclusions as far as craving and relapse prediction are concerned.
-
Revue médicale suisse · Jun 2015
Case Reports[Trauma and chronic pain: echoes and amplifications of physical and emotional suffering].
Chronic pain often presents following a traumatic event, or alternatively, patients attribute pain to a trauma, whether this link is established or not. The psychological impact of trauma can significantly complicate the treatment of chronic pain. This article aims to review the known interactions between trauma and chronic pain. Following this review, it discusses therapeutic avenues suited to these complex situations, underlining the specific contributions of the different members of a multidisciplinary team.
-
Revue médicale suisse · Jun 2015
[Chronic noncancer pain and patient education: a place for e-learning?].
Chronic non cancerous pain considerably limits the patients' quality of life. Yet, chronic non cancerous pain has a prevalence as high as 25% to 35%, Therapeutic education allows to work on the knowledge and know-how about the disease, the treatment, the management of health resources and health behaviors. ⋯ The level of proof of its efficacy is weak, mainly because of methodological limitations. Some good quality studies are promising, with a positive effect of e-learning programs on pain intensity, disability, autonomy and medication misuse.
-
Revue médicale suisse · Jun 2015
[PIPAC--Pressurized intraperitoneal aerosol chemotherapy. A novel treatment for peritoneal carcinomatosis].
Peritoneal carcinomatosis remains a diagnostic challenge with sparse treatment options. The effect of systemic chemotherapy remains limited inside the peritoneum due to low penetration and a relative resistance of peritoneal nodules. Heated IntraPeritoneal Chemotherapy (HIPEC) improves survival in selected patients but entails a high incidence of complications. ⋯ Distribution and tissue penetration of chemotherapy by PIPAC are superior to HIPEC and systemic chemotherapy despite of lower doses. Systemic side effects are uncommon and surgical trauma is limited. Histological and clinical response rates in platinum-resistant patients approach 70% and survival data appear to be favorable compared with standard therapy.